Evidence map›Paper›PMID 34296454›Full record

ArticleThe EMBO journal2021

The TOR-dependent phosphoproteome and regulation of cellular protein synthesis.

Tiffany Mak, Andrew W Jones, Paul Nurse

Open access · hybridAbstract read
In one paragraph

Article in The EMBO journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Target of Rapamycin Regulates Photosynthesis and Cell Growth inInternational journal of molecular sciences · 2022
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 2 countries.

Tiffany MakCell Cycle Laboratory, The Francis Crick Institute, London, UK.ORCID 0000-0001-6134-4999
Andrew W JonesCell Cycle Laboratory, The Francis Crick Institute, London, UK.
Paul NurseCell Cycle Laboratory, The Francis Crick Institute, London, UK.
The Francis Crick Institute · GB

Funding

Cancer Research UK FC01121Medical Research Council FC01121Wellcome Trust 093917Wellcome Trust 214183Wellcome Trust FC001121Wellcome Trust FC01121
6 · The paper itself

Abstract

Cell growth is orchestrated by a number of interlinking cellular processes. Components of the TOR pathway have been proposed as potential regulators of cell growth, but little is known about their immediate effects on protein synthesis in response to TOR-dependent growth inhibition. Here, we present a resource providing an in-depth characterisation of Schizosaccharomyces pombe phosphoproteome in relation to changes observed in global cellular protein synthesis upon TOR inhibition. We find that after TOR inhibition, the rate of protein synthesis is rapidly reduced and that notable phosphorylation changes are observed in proteins involved in a range of cellular processes. We show that this reduction in protein synthesis rates upon TOR inhibition is not dependent on S6K activity, but is partially dependent on the S. pombe homologue of eIF4G, Tif471. Our study demonstrates the impact of TOR-dependent phospho-regulation on the rate of protein synthesis and establishes a foundational resource for further investigation of additional TOR-regulated targets both in fission yeast and other eukaryotes.

Indexed as

PhosphoproteinsPhosphorylationProtein BiosynthesisProteomeSchizosaccharomycesSchizosaccharomyces pombe ProteinsTOR Serine-Threonine KinasesPhosphoproteinsProteomeSchizosaccharomyces pombe ProteinsTOR Serine-Threonine Kinasesphosphoproteomicsprotein synthesisTOR regulation

Identifiers

PMID34296454
PMCPMC8365262
OpenAlexW3184699480

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.